TY - JOUR
AU - R. Persson
AU - M. Cordey
AU - M. Paris
AU - S. Jick
AD - Boston Collaborative Drug Surveillance Program, 11 Muzzey Street, Lexington, MA, 02421, USA.
Amgen Inc., Thousand Oaks, CA, USA.
Boston Collaborative Drug Surveillance Program, 11 Muzzey Street, Lexington, MA, 02421, USA. sjick@bu.edu.
Boston University School of Public Health, Boston, MA, USA. sjick@bu.edu.
AN - 36151359
BT - Drug Saf
C2 - PMC9510500 Myriam Cordey and Maria Paris are employees of Amgen Inc. Susan Jick received research grants to her institution and is a consultant for Amgen Inc.
DO - 10.1007/s40264-022-01235-7
DP - NLM
ET - 2022/09/24
LA - eng
N1 - 1179-1942
Persson, Rebecca
Cordey, Myriam
Paris, Maria
Jick, Susan
Orcid: 0000-0002-2215-1067
Journal Article
Drug Saf. 2022 Sep 23:1-9. doi: 10.1007/s40264-022-01235-7.
PY - 2022
SN - 0114-5916 (Print)
0114-5916
SP - 1
EP - 9
T2 - Drug Saf
TI - Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
ER -